Patents by Inventor Michael J. Fitch

Michael J. Fitch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220257266
    Abstract: An intracranial access device includes a housing having an operator-facing side and a patient-facing side and an opening therethrough extending from the operator-facing side to the patient-facing side. The device further includes at least one fastener configured to secure the device to a cranium of a patient. The device further includes a drill mounted to a surface of the housing and a cauterizer. The device may further include a number of sensors arranged on the patient-facing side of the housing and configured to identify a hemorrhage location.
    Type: Application
    Filed: July 16, 2020
    Publication date: August 18, 2022
    Applicants: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Johns Hopkins University
    Inventors: David L. Brody, David Blodgett, Carissa Rodriguez, Timothy Sleasman, Michael J. Fitch, Adam Cohen, Max R. Basescu, Kevin C. Wolfe, Jared M. Wormley
  • Publication number: 20220042849
    Abstract: A system includes first and second radiation sources, first and second detectors, a signal digitizer, a controller, and an analyzer. The first and second radiation sources generate respective first and second beams of radiation to irradiate a target. The first beam and second beams each include a first wavelength operated at a first modulation frequency and a second wavelength operated at a second modulation frequency. The first and second detectors each include a photo-sensitive element that generate first or second detection signals, a Faraday shielding enclosure, a signal amplifier, and a frequency mixer to frequency-adjust the first or second detection signals. The controller provides timing information to inform an activation scheme of the first and second radiation sources and corresponding radiation detection events at the first and second detectors. The analyzer analyzes the first and second detection signals and determines at least amplitude and phase information of the scattered radiation.
    Type: Application
    Filed: August 4, 2021
    Publication date: February 10, 2022
    Inventors: Scott M. Hendrickson, Jeremiah J. Wathen, Michael J. Fitch, David W. Blodgett, Vincent R. Pagan
  • Patent number: 9873722
    Abstract: The invention provides novel Wnt polypeptides that have improved production characteristics, solubility, systemic delivery, and tissue uptake, and polynucleotides encoding the Wnt polypeptides of the invention. The Wnt polypeptides of the invention can be used therapeutically, such as, for example, in methods of preventing or treating muscle loss and/or promoting muscle hypertrophy and growth.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: January 23, 2018
    Assignee: Fate Therapeutics, Inc.
    Inventors: Tom Tong Lee, Michael J. Fitch, Kevin Lai, Peter Flynn, Monica Bennett
  • Patent number: 9403885
    Abstract: The invention provides novel Wnt polypeptides that have enhanced solubility and improved biologic drug-like properties, and polynucleotides encoding the Wnt polypeptides of the invention. The Wnt polypeptides of the invention can be used therapeutically, such as, for example, in methods of preventing or treating muscle loss and/or promoting muscle hypertrophy and growth.
    Type: Grant
    Filed: January 11, 2012
    Date of Patent: August 2, 2016
    Assignee: Fate Therapeutics, Inc.
    Inventors: Tom Tong Lee, Monica Hayhurst Bennett, Michael J. Fitch, Peter Flynn
  • Publication number: 20150099708
    Abstract: The invention provides novel Wnt polypeptides that have improved production characteristics, solubility, systemic delivery, and tissue uptake, and polynucleotides encoding the Wnt polypeptides of the invention. The Wnt polypeptides of the invention can be used therapeutically, such as, for example, in methods of preventing or treating muscle loss and/or promoting muscle hypertrophy and growth.
    Type: Application
    Filed: September 14, 2012
    Publication date: April 9, 2015
    Inventors: Tom Tong Lee, Michael J. Fitch, Kevin Lai, Peter Flynn, Monica Bennett
  • Publication number: 20140142046
    Abstract: The invention provides novel Wnt polypeptides that have enhanced solubility and improved biologic drug-like properties, and polynucleotides encoding the Wnt polypeptides of the invention. The Wnt polypeptides of the invention can be used therapeutically, such as, for example, in methods of preventing or treating muscle loss and/or promoting muscle hypertrophy and growth.
    Type: Application
    Filed: January 11, 2012
    Publication date: May 22, 2014
    Applicant: FATE THERAPEUTICS, INC.
    Inventors: Tom Tong Lee, Monica Hayhurst Bennett, Michael J. Fitch, Peter Flynn
  • Patent number: 7006267
    Abstract: Techniques for high fidelity quantum teleportation include receiving an input photon representing a qubit. Ancilla photons are generated in a particular ancilla quantum state chosen to reduce a rate of error below a threshold error rate. The ancilla and the input photon are combined to populate output channels. A number of photons representing logical value 1 are measured in a subset of the output channels. A particular output channel is determined based on the measured number of photons. A teleported photon is obtained at the particular output channel with an error rate below the threshold error rate. These techniques allow the ancilla quantum state to be chosen to minimize the error despite the presence of losses and noise. Quantum logic operations are performed by teleporting two input qubits with the quantum state of the ancilla chosen to produce the desired logical result and reduce the error.
    Type: Grant
    Filed: August 28, 2003
    Date of Patent: February 28, 2006
    Assignee: The Johns Hopkins University
    Inventors: James D. Franson, Michelle M. Donegan, Michael J. Fitch, Bryan C. Jacobs, Todd B. Pittman
  • Publication number: 20040109631
    Abstract: Techniques for high fidelity quantum teleportation include receiving an input photon representing a qubit. Ancilla photons are generated in a particular ancilla quantum state chosen to reduce a rate of error below a threshold error rate. The ancilla and the input photon are combined to populate output channels. A number of photons representing logical value 1 are measured in a subset of the output channels. A particular output channel is determined based on the measured number of photons. A teleported photon is obtained at the particular output channel with an error rate below the threshold error rate. These techniques allow the ancilla quantum state to be chosen to minimize the error despite the presence of losses and noise. Quantum logic operations are performed by teleporting two input qubits with the quantum state of the ancilla chosen to produce the desired logical result and reduce the error.
    Type: Application
    Filed: August 28, 2003
    Publication date: June 10, 2004
    Inventors: James D. Franson, Michelle M. Donegan, Michael J. Fitch, Bryan C. Jacobs, Todd B. Pittman
  • Patent number: D958341
    Type: Grant
    Filed: November 25, 2020
    Date of Patent: July 19, 2022
    Assignee: WELCH ALLYN, INC.
    Inventors: Alan S. Knieriem, Thaddeus J. Wawro, Timothy R. Fitch, Robert S. Englert, Michael T. McMahon, David Perkins
  • Patent number: D958342
    Type: Grant
    Filed: November 25, 2020
    Date of Patent: July 19, 2022
    Assignee: WELCH ALLYN, INC.
    Inventors: Alan S. Knieriem, Thaddeus J. Wawro, Timothy R. Fitch, Robert S. Englert, Michael T. McMahon, David Perkins